NephroDI Therapeutics
Latest round
- Series A
Last raised
- Jun 2024
Total raised
- $2M
Investors
- 1
About NephroDI Therapeutics
Based in Pennsylvania, US, and founded in 2017 by Ish Khanna, Janet D. Klein, Jeff M. Sands, and Ram Pillarisetti, NephroDI Therapeutics, Inc. is a pharmaceutical company developing an oral drug to treat Nephrogenic Diabetes Insipidus (NDI) in children. As of 2022, Rachael Hagan is the CEO of the company. The company is developing NDI-5033, which is a unique adenosine monophosphate activated kinase (AMPK) activator that can stimulate water reabsorption without causing hypoglycemia, decreasing overall urine output for the treatment of Nephrogenic Diabetes Insipidus (NDI).
Who invested in NephroDI Therapeutics
1 investor across 1 round
See all investors in NephroDI Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 11, 2024
Amount
$2M
Investors
Questions about NephroDI Therapeutics
Who invested in NephroDI Therapeutics?
NephroDI Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NephroDI Therapeutics raised?
NephroDI Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NephroDI Therapeutics last raise money?
NephroDI Therapeutics's most recent round on record is a Series A, in Jun 2024.
What does NephroDI Therapeutics do?
Based in Pennsylvania, US, and founded in 2017 by Ish Khanna, Janet D.
Where is NephroDI Therapeutics headquartered?
NephroDI Therapeutics is headquartered in Seattle, US.
Which VCs invest in companies like NephroDI Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at NephroDI Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like NephroDI Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.